466 related articles for article (PubMed ID: 33166547)
1. A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex.
Eydoux C; Fattorini V; Shannon A; Le TT; Didier B; Canard B; Guillemot JC
J Virol Methods; 2021 Feb; 288():114013. PubMed ID: 33166547
[TBL] [Abstract][Full Text] [Related]
2. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
[TBL] [Abstract][Full Text] [Related]
3. A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19.
Jockusch S; Tao C; Li X; Anderson TK; Chien M; Kumar S; Russo JJ; Kirchdoerfer RN; Ju J
Antiviral Res; 2020 Aug; 180():104857. PubMed ID: 32562705
[TBL] [Abstract][Full Text] [Related]
4. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
5. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
[TBL] [Abstract][Full Text] [Related]
6. High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery.
Ge F; Xiong S; Lin FS; Zhang ZP; Zhang XE
Antiviral Res; 2008 Nov; 80(2):107-13. PubMed ID: 18584889
[TBL] [Abstract][Full Text] [Related]
7. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
[TBL] [Abstract][Full Text] [Related]
8. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.
Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS
J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399
[TBL] [Abstract][Full Text] [Related]
9. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.
Bai X; Sun H; Wu S; Li Y; Wang L; Hong B
Front Immunol; 2022; 13():844749. PubMed ID: 35464436
[TBL] [Abstract][Full Text] [Related]
10. Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus.
Sevajol M; Subissi L; Decroly E; Canard B; Imbert I
Virus Res; 2014 Dec; 194():90-9. PubMed ID: 25451065
[TBL] [Abstract][Full Text] [Related]
11. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture.
te Velthuis AJ; van den Worm SH; Sims AC; Baric RS; Snijder EJ; van Hemert MJ
PLoS Pathog; 2010 Nov; 6(11):e1001176. PubMed ID: 21079686
[TBL] [Abstract][Full Text] [Related]
12. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.
Hertzig T; Scandella E; Schelle B; Ziebuhr J; Siddell SG; Ludewig B; Thiel V
J Gen Virol; 2004 Jun; 85(Pt 6):1717-1725. PubMed ID: 15166457
[TBL] [Abstract][Full Text] [Related]
13. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery.
Zhu W; Chen CZ; Gorshkov K; Xu M; Lo DC; Zheng W
SLAS Discov; 2020 Dec; 25(10):1141-1151. PubMed ID: 32660307
[TBL] [Abstract][Full Text] [Related]
14. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.
Snijder EJ; Bredenbeek PJ; Dobbe JC; Thiel V; Ziebuhr J; Poon LL; Guan Y; Rozanov M; Spaan WJ; Gorbalenya AE
J Mol Biol; 2003 Aug; 331(5):991-1004. PubMed ID: 12927536
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates.
Ahn DG; Choi JK; Taylor DR; Oh JW
Arch Virol; 2012 Nov; 157(11):2095-104. PubMed ID: 22791111
[TBL] [Abstract][Full Text] [Related]
16. Helicases as antiviral drug targets.
Huang JD; Zheng BJ; Sun HZ
Hong Kong Med J; 2008 Aug; 14 Suppl 4():36-8. PubMed ID: 18708673
[TBL] [Abstract][Full Text] [Related]
17. A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.
Shema Mugisha C; Vuong HR; Puray-Chavez M; Bailey AL; Fox JM; Chen RE; Wessel AW; Scott JM; Harastani HH; Boon ACM; Shin H; Kutluay SB
mSphere; 2020 Sep; 5(5):. PubMed ID: 32878932
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay.
Zhou Y; Agudelo J; Lu K; Goetz DH; Hansell E; Chen YT; Roush WR; McKerrow J; Craik CS; Amberg SM; Simmons G
Antiviral Res; 2011 Nov; 92(2):187-94. PubMed ID: 21820471
[TBL] [Abstract][Full Text] [Related]
19. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.
Aftab SO; Ghouri MZ; Masood MU; Haider Z; Khan Z; Ahmad A; Munawar N
J Transl Med; 2020 Jul; 18(1):275. PubMed ID: 32635935
[TBL] [Abstract][Full Text] [Related]
20. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
